CLEVELAND, Oct. 11, 2016 (GLOBE NEWSWIRE) -- Athersys, Inc. (Nasdaq:ATHX) will release its third quarter 2016
financial results at approximately 4:00 PM Eastern Time on Wednesday, November 9, 2016, and host a conference call shortly
thereafter at 4:30 PM Eastern Time to review the results. Gil Van Bokkelen, Chairman and Chief Executive Officer, and William
(B.J.) Lehmann, President and Chief Operating Officer, will host the call as follows:
|
Date |
November 9, 2016 |
| Time |
4:30 p.m. (Eastern
Time) |
| Telephone
access: US and Canada |
(800) 273-1254 |
| Telephone
access: International |
(973) 638-3440 |
| Access
code |
97839505 |
| Live
webcast |
www.athersys.com under Investors section
|
A replay will be available for on-demand listening shortly after the completion of the call until 11:59 PM
Eastern Time on November 23, 2016 at the aforementioned URL, or by dialing (800) 585-8367 or (855) 859-2056 in the U.S. and Canada,
or from abroad (404) 537-3406, and entering access code 97839505.
About Athersys
Athersys is an international biotechnology company engaged in the discovery and development of therapeutic
product candidates designed to extend and enhance the quality of human life. The Company is developing its MultiStem®
cell therapy product, a patented, adult-derived "off-the-shelf" stem cell product, initially for disease indications in the
cardiovascular, neurological, inflammatory and immune disease areas, and has several ongoing clinical trials evaluating this
potential regenerative medicine product. Athersys has forged strategic partnerships and collaborations with leading pharmaceutical
and biotechnology companies, as well as world-renowned research institutions to further develop its platform and products. More
information is available at www.athersys.com.
ATH-G
Contact: William (B.J.) Lehmann, J.D. President and Chief Operating Officer Tel: (216) 431-9900 bjlehmann@athersys.com
